ICAHN School of Medicine At Mount Sinai
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1963-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mssm.edu
Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 47
- Registration Number
- NCT00463060
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
Phase 4
Terminated
- Conditions
- Postoperative Cognitive DysfunctionPOCDPostoperative DeliriumPD
- Interventions
- Drug: Precedex (Dexmedetomidine)Drug: Placebo
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 27
- Registration Number
- NCT00455143
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Improving Metabolic Control in Diabetic Young Children
Not Applicable
Terminated
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Behavioral: Cognitive Behavioral Therapy
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 23
- Registration Number
- NCT00439985
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
Phase 4
Completed
- Conditions
- Upper Limb Spasticity
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2007-02-01
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 135
- Registration Number
- NCT00430196
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
Not Applicable
Completed
- Conditions
- Eating Disorders
- Interventions
- Behavioral: Individual Supportive PsychotherapyBehavioral: Family-Based Therapy ("Maudsley Method")
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 59
- Registration Number
- NCT00418977
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 51
- Registration Number
- NCT00413244
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth
Not Applicable
Completed
- Conditions
- Oppositional Defiant DisorderConduct Disorder
- Interventions
- Behavioral: MFG therapyBehavioral: Standard of Care
- First Posted Date
- 2006-11-29
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 416
- Registration Number
- NCT00404911
- Locations
- 🇺🇸
Mount Sinai's Child and Adolescent Outpatient Psychiatry Clinic, New York, New York, United States
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
Not Applicable
Completed
- Conditions
- Stress Disorders, Post-Traumatic
- Interventions
- Behavioral: Cognitive behavioral therapy (CBT)Behavioral: Educational session and treatment as usual
- First Posted Date
- 2006-08-16
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 60
- Registration Number
- NCT00364910
- Locations
- 🇺🇸
Elmhurst Hospital Center, Queens, New York, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Guanfacine to Treat Borderline Personality Disorder
Not Applicable
- Conditions
- Borderline Personality Disorder
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2006-08-01
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Registration Number
- NCT00358969
- Locations
- 🇺🇸
Mount Sinai Hospital - Mood & Personality Research Group, New York, New York, United States
Pharmacology of Cognition in Schizotypal Personality Disorder
Phase 4
Terminated
- Conditions
- Schizotypal Personality DisorderPersonality Disorders
- Interventions
- Drug: GuanfacineDrug: Placebo
- First Posted Date
- 2006-07-18
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 29
- Registration Number
- NCT00353379
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath